A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy
A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy
A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
65
Years old
Gender
All
Therapeutic area :
Central Nervous System
Disease :
Peripheral diabetic neuropathy
Study medication :
Befiradol
Phase :
Phase II
Start Date :
27 October 2009
End date :
09 December 2010
Study ID :
F13640 CP 201
EudraCT/CTIS number :
2009-012123-28
Send by email